News Releases

Researchers to Present on Genetic Testing, Precision Medicine, Care Delivery & Physician Workforce Research

NASHVILLE, Tenn., Oct. 17, 2023 /PRNewswire/ -- OneOncology, the national platform for independent oncology practices, announced today that researchers at OneOncology and its partner practices will present 11 abstracts at the upcoming ASCO Quality Care Symposium October 27-28.

Neha Jain, Ph.D., OneOncology's Senior Director of Precision Medicine, will present "Provider Messaging for Precision Treatment (ProMPT): A Notification Pilot to Inform Actionable Genomic Findings."  Through the ProMPT pilot project, OneOncology leverages the raw genomic data feed from Next Generation Sequencing vendors by:

• performing a weekly query for all the patients with a signed molecular test report;
• examining the reported mutations to assess testing adequacy and;  
• matching those patients with FDA-approved precision therapies or institutional clinical trials.

The next iteration of ProMPT will use OneOncology's proprietary analytics platform to incorporate genomic information into our physicians' workstream.

Tennessee Oncology researchers will present six abstracts addressing topics including clinical innovation, care delivery, OCM learnings and implications for value-based care, automating behavior economics and analytics to improve palliative care, and scaling oncology disease expertise in urban and rural clinics. The Tennessee Oncology abstract authors are L. Johnetta Blakely, MD, MMHC, MS; Leah Owens, DNP, OCN, RN; Christy Schneider; Sandhya Mudumbi, MD; Ashley Wyse, NP-C; Michael T. Byrne, MD, and Katherine Baker MD, MMHC.

Ray Page, DO, PhD, FACOI, FASCO, who practices at The Center for Cancer and Blood Disorders in Fort Worth, Texas, is an author on two abstracts chosen for oral and poster presentation. "The State of Professional Wellbeing and Satisfaction Among US Oncologists" was selected for oral presentation while "The State of Workforce Retention Among US Oncologists" was selected for a poster presentation.

Joining first author, Melissas Cruz, LPN, OPN-CG, Manager Patient Navigation Services, Astera Cancer Care, is Ellen Ronnen, MD, Astera Cancer Care's Chief Medical Officer, on the abstract "Enhancing Precision Medicine Testing Process in a Breast Cancer Population of a Community Oncology Practice: Use of Oncology Patient Navigators (OPN) and a Molecular Processing Team (MPT) to Improve Germline Testing." This research examines how Astera Cancer Care's Oncology Patient Navigators and a Molecular Processing Team use the Electronic Health Record to optimize germline testing for eligible breast cancer patients. Germline testing is genetic testing that identifies a person's inherited mutations, which can help oncologists determine the best treatment for patients. Results of germline testing also inform recommended earlier screening and diagnostics for a patient's first-degee relatives (children, parents, and siblings) who may have inherited mutated genes.

Dr. Ronnen is also an author on "Using an Electronic Capture Geriatric Assessment to Guide Rehabilitation Triage for Adults with Cancer During Systemic Therapy," which uses an electronic capture to get elderly patients going on chemotherapy an ASCO-recommended frailty assessment and an introduction to Physical Therapy or Occupational Therapy, both of which are proven to improve quality of life with regular use. Dr. Ronnen was joined by Astera Cancer Care's Rachel Carroll, MSN, FNP-BC, AOCNP as an author on the abstract.

The lineup of abstracts is as follows:

SOURCE OneOncology, LLC.